Intra lesional injection of triamcinolone acetonide- An aesthetic method of treating chalazion

---

Original Article

Author Details : K. Kavita, Mohammed Ather, Samra Wahaaj Fatima

Volume : 4, Issue : 1, Year : 2018

Article Page : 27-29

https://doi.org/10.18231/2455-8478.2018.0009

Suggest article by email

Get Permission

---

Abstract

Aim: To study the efficacy of intra lesional injection of triamcinolone acetonide in treating chalazion.

Materials and Method: This is a prospective interventional study conducted on 100 cases of chalazion at the department of Oculoplasty and orbital disease of Sarojini Devi eye hospital, during July 2013 to June 2015. 100 cases of chalazion who came to the out patient department of Sarojini Devi Eye Hospital were included in the study. Recurrent cases, cases of acute hordeolum internum, Lid malignancies, and children were excluded from the study.

Informed consent was obtained from cases selected. They were investigated for Routine surgical profile and size of chalazion measured in millimetres by a transparent ruler. Then Injection of 0.1 ml of triamcinolone was given intra lesionally into the chalazion in minor operation theatre taking all Aseptic Precautions. Cases were followed post operatively after I^st week and fourth week for reduction in size of chalazion.

Result: Out of 100 cases 80 had complete resolution, 11 had reduction in size and 9 didn’t respond to treatment.

Conclusion: Intra lesional injection of triamcinolone is Aesthetic method of treating chalazion. 

Keywords: Chalazion, Intra lesional injection, Triamcinolone acetonide

How to cite : Kavita K, Ather M, Fatima S W, Intra lesional injection of triamcinolone acetonide- An aesthetic method of treating chalazion. IP Int J Ocul Oncol Oculoplasty 2018;4(1):27-29

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.